NCT07270510

Brief Summary

This study is aimed at assessing the effect of an animal-derived collagen matrix on bone and soft tissues in the human teeth. Single-rooted teeth that are beyond restoration and in need of extraction will be included in the study. Patients will be divided into two comparable groups in a randomized manner. The first group will proceed with tooth extraction only, which will be left for spontaneous healing. The second (test) group will receive an additional collagen matrix graft after the extraction, which will be sutured to the tooth socket. Sutures will be removed 1 week after surgery. Both groups will undergo CBCT imaging on the day of surgery and at the 3-month follow-up. Differences in bone measurements like height and width will be recorded as well as soft tissue measurements like thickness and width. Data acquired from two groups will be compared against each other to specify the protective effect of the applied collagen matrix graft.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jul 2025

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2026

Completed
Last Updated

December 8, 2025

Status Verified

November 1, 2025

Enrollment Period

6 months

First QC Date

November 26, 2025

Last Update Submit

November 26, 2025

Conditions

Keywords

collagen matrixalveolar socket preservationalveolar ridgebone resorptionsocket seal

Outcome Measures

Primary Outcomes (2)

  • Buccal Height (BH)

    Measurement of Buccal Height using CBCT scans

    From intervention day to 3 months follow-up

  • Buccal Width (BW)

    Buccal Width measurements using CBCT scans

    From intervention day to 3-month follow-up

Secondary Outcomes (4)

  • Palatal/lingual Height (PH)

    From intervention day to 3-month follow-up

  • Palatal/lingual Width (PW)

    From intervention day to 3-month follow-up

  • Gingival Thickness (GT)

    From intervention day to 3-month follow-up

  • Keratinized Tissue Width (KTW)

    From intervention day to 3-month follow-up

Study Arms (2)

Control Group

NO INTERVENTION

The control group only went through routine tooth extractions without further interventions. Extraction sockets were left to spontaneous healing.

Test Group

ACTIVE COMPARATOR

The test group received Collagen Matrix onto their extraction sockets after extractions.

Device: Collagen Matrix soft tissue graft

Interventions

Circular 8 mm diameter collagen matrix grafts were sutured to seal extraction sockets in the participants. The sutures were removed 1 week after the intervention.

Test Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults (absence of cardiovascular diseases, thyroid diseases, oncological diseases Non-smokers Extraction diagnosis on non-molar teeth Gingivitis, stage 1-2 periodontitis conditions Absence of radiotherapy last 2 years Non restorable teeth (deep fracture, excessive caries, failed root canal treatment) Overall plaque score and gingival score of \<10%

You may not qualify if:

  • Systemically compromised patients Smokers Pregnancy or lactation Heavy periodontally compromised patients (Stage 3-4) Patients undergone radiotherapy in the last 2 years Collagen allergic patients Restorable teeth Overall plaque score and gingival score of \>10%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Altinbas University

Istanbul, Istanbul, 34147, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Bone Resorption

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Study Officials

  • Sebnem Dirikan Ipci, Prof.

    Altinbas University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessor was blinded to minimize data analysis bias..
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study is a parallel arm randomized clinical trial consisting of a control and a test group with same number of participants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 26, 2025

First Posted

December 8, 2025

Study Start

July 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 20, 2026

Last Updated

December 8, 2025

Record last verified: 2025-11

Locations